May 5, 2026 Alpha Tau Announces Upcoming Podium Presentation at the AHNS 12th International Conference on Head and Neck Cancer Showcasing Study Results of Alpha DaRT® Head and Neck Cancer Combination with Pembrolizumab
May 5, 2026 Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment
May 5, 2026 CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Driven Brands Holdings Inc. (NASDAQ: DRVN) Investors to Inquire About a Securities Fraud Class Action by May 8, 2026